After writing dozens of GLP-1 articles over the past year, one issue that consistently comes up is the affordability of ...

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...

Hims & Hers Health, Inc. could see more upside in partnerships and international expansion. Click here to read an analysis of ...

Weight-loss medicines like Semaglutide (GLP – 1RA), originally developed to help people with type 2 diabetes manage their ...

Zydus Lifesciences Ltd and Torrent Pharmaceuticals Ltd are preparing to enter the fast-growing market for Semaglutide — a ...

NVO's new U.S. pricing deal for Ozempic and Wegovy expands access but adds uncertainty to its growth and profit outlook.

Novo Nordisk A/S & Eli Lilly and Company cut prices for top diabetes drugs, boosting accessibility and potential revenue.

Direct-to-consumer (DTC) telehealth companies remove barriers to care, but questions remain regarding patient safety and proper information.

As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...

Novo Nordisk is under pressure from cheap copycats, a Trump pricing deal, and Lilly's fast-growing Zepbound juggernaut.

Pennsylvanians deserve better than counterfeit medicine cooked up in back rooms and peddled through predatory online ads.

Metsera said it expects the Pfizer deal to close promptly after a stockholder meeting scheduled for this coming Thursday ...